Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Embla Medical hf (OSSFF) vs. Competitors

14 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
OSSFFEmbla Medical hf$4.00$1.72B18.23-23.54%Moderate BuyUnlock the OSSFF analyst price target with TipRanks PremiumOSSFFUnlock the OSSFF top-analyst price target with TipRanks Premium
SNNSmith & Nephew Snats$30.51$12.72B20.02-6.32%HoldUnlock the SNN analyst price target with TipRanks PremiumOSSFF vs SNNUnlock the SNN top-analyst price target with TipRanks Premium
ZBHZimmer Biomet Holdings$102.09$19.32B25.9215.17%Moderate BuyUnlock the ZBH analyst price target with TipRanks PremiumOSSFF vs ZBHUnlock the ZBH top-analyst price target with TipRanks Premium
SYKStryker$317.54$120.88B33.61-11.83%Strong BuyUnlock the SYK analyst price target with TipRanks PremiumOSSFF vs SYKUnlock the SYK top-analyst price target with TipRanks Premium
MDTMedtronic$102.32$130.88B25.136.27%Moderate BuyUnlock the MDT analyst price target with TipRanks PremiumOSSFF vs MDTUnlock the MDT top-analyst price target with TipRanks Premium
BSXBoston Scientific$43.03$62.37B18.21-57.71%Moderate BuyUnlock the BSX analyst price target with TipRanks PremiumOSSFF vs BSXUnlock the BSX top-analyst price target with TipRanks Premium
GMEDGlobus Medical$69.99$9.27B16.99-16.32%Moderate BuyUnlock the GMED analyst price target with TipRanks PremiumOSSFF vs GMEDUnlock the GMED top-analyst price target with TipRanks Premium

Performance Comparison

-60%-40%-20%0%20%40%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
OSSFFEmbla Medical hf4.00-1.06-20.97%
SNNSmith & Nephew Snats30.51-0.95-3.01%
ZBHZimmer Biomet Holdings102.0913.5915.35%
SYKStryker317.54-42.70-11.85%
MDTMedtronic102.325.205.35%
BSXBoston Scientific43.03-53.98-55.64%
GMEDGlobus Medical69.99-13.83-16.50%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts